Department of Internal Medical, Affiliated Hospital of Shandong Medical College, Linyi, Shandong, China (mainland).
Department of Obstetrics and Gynecology, The Affiliated Hospital of ShanDong Medical College, Linyi, Shandong, China (mainland).
Med Sci Monit. 2016 Oct 19;22:3828-3834. doi: 10.12659/msm.897122.
BACKGROUND Because genotype CG/GG of Furin rs2071410 can increase susceptibility to hypertension, this study investigated whether Furin rs2071410 is correlated with transient ischemic attack (TIA) susceptibility and prognosis. MATERIAL AND METHODS The odds ratios (ORs) and their 95% confidence intervals (95% CIs) were evaluated to assess the association of rs2071410 with TIA risk, and logistic regression was used to estimate the effects of various risk factors (e.g., diabetes, hypertension, and hyperlipidemia) on TIA. RESULTS Compared with the homozygous genotype CC of rs2071410, the frequency of CG + GG genotype in the case group was significantly higher than in the control group (OR=1.47, 95% CI: 1.05-2.05, P<0.05). The CG + GG genotype carriers were observed to have worse 90-day prognosis after TIA treatment than patients carrying CC genotype (OR=12.86, 95% CI: 7.41-22.33, P<0.05). Moreover, logistic regression analysis found that age, diabetes, hypertension, and hyperlipidemia were associated with the onset of TIA (P<0.05, all). Of note, individuals with CG + GG genotype had 49.3% increased risk of TIA compared with individuals with CC genotype (OR=1.49, 95% CI: 1.05-2.12), and patients with CG + GG genotype had worse 90-day prognosis after TIA treatment than patients with CC genotype (OR=11.39, 95% CI: 6.29-20.62). CONCLUSIONS Furin rs2071410 was significantly correlated with TIA occurrence and prognosis in the Chinese population.
Furin rs2071410 的 CG/GG 基因型可增加患高血压的易感性,因此本研究探讨了 Furin rs2071410 是否与短暂性脑缺血发作(TIA)易感性和预后相关。
采用优势比(OR)及其 95%置信区间(95%CI)评估 rs2071410 与 TIA 风险的相关性,采用 logistic 回归估计各种危险因素(如糖尿病、高血压和高脂血症)对 TIA 的影响。
与 rs2071410 的纯合基因型 CC 相比,病例组 CG+GG 基因型的频率明显高于对照组(OR=1.47,95%CI:1.05-2.05,P<0.05)。TIA 治疗后,CG+GG 基因型携带者的 90 天预后较 CC 基因型携带者更差(OR=12.86,95%CI:7.41-22.33,P<0.05)。此外,logistic 回归分析发现年龄、糖尿病、高血压和高脂血症与 TIA 的发生有关(P<0.05,均)。值得注意的是,与 CC 基因型携带者相比,CG+GG 基因型携带者发生 TIA 的风险增加了 49.3%(OR=1.49,95%CI:1.05-2.12),并且 CG+GG 基因型携带者的 90 天预后较 CC 基因型携带者更差(OR=11.39,95%CI:6.29-20.62)。
Furin rs2071410 与中国人群 TIA 的发生和预后显著相关。